
Aflibercept Dose in Polypoidal Choroidal Vasculopathy
18/12/2025 | 16 min
Interview with Tien Y. Wong, MD, PhD, author of Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content: Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy

The Central Role of Home Hazards in Shaping the Association of Visual Function and Falls in Older Adults
11/12/2025 | 13 min
Interview with Joshua R. Ehrlich, MD, MPH author of The Central Role of Home Hazards in Shaping the Association of Visual Function and Falls in Older Adults. Hosted by Neil Bressler, MD. Related Content: The Role of Home Hazards in the Association Between Visual Function and Falls in Older Adults

Foundation Models vs Physicians in Ophthalmological Questions
13/11/2025 | 15 min
Interview with Darren Shu Jeng Ting, MBChB, PhD, author of Performance of Foundation Models vs Physicians in Textual and Multimodal Ophthalmological Questions. Hosted by Neil Bressler, MD. Related Content: Performance of Foundation Models vs Physicians in Textual and Multimodal Ophthalmological Questions Mastering Ophthalmology in the Digital Age

Retinal Sensitivity and Retinal Perfusion in Diabetic Retinopathy
30/10/2025 | 16 min
Interview with Noemi Lois, MD, PhD, author of Retinal Sensitivity and Retinal Perfusion in Diabetic Retinopathy. Hosted by Neil Bressler, MD. An earlier posted version of this podcast may not have stated clearly enough that in areas with loss of perfusion and loss of sensitivity at baseline which remained non-perfused during the follow up, the sensitivity deficit declined over time. This has been corrected in the podcast. Related Content: Retinal Sensitivity and Retinal Perfusion in Diabetic Retinopathy

Diabetes in the Donor and Descemet Membrane Endothelial Keratoplasty Success at 1 Year
17/10/2025 | 16 min
Interview with Jonathan H. Lass, MD, author of Donor Diabetes and 1-Year Descemet Membrane Endothelial Keratoplasty Success Rate: A Randomized Clinical Trial and of Endothelial Cell Loss 1 Year After Successful DMEK in the Diabetes Endothelial Keratoplasty Study: A Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content: Endothelial Cell Loss 1 Year After Successful DMEK in the Diabetes Endothelial Keratoplasty Study Donor Diabetes and 1-Year Descemet Membrane Endothelial Keratoplasty Success Rate Impact of the Diabetes Endothelial Keratoplasty Study



JAMA Ophthalmology Author Interviews